Monitoring MRD in ALL: Methodologies, technical aspects and optimal time points for measurement
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference77 articles.
1. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia;Fielding;Blood,2014
2. Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation;Gokbuget;Blood,2012
3. Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial;Sive;Br J Haematol,2012
4. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study;Borowitz;Blood,2008
5. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial;Vora;Lancet Oncol,2013
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Use of Flow Cytometry for MRD Detection of B- and T-ALL in Pediatric Patients;Reference Module in Biomedical Sciences;2024
2. Minimal Residual Disease in Acute Lymphoblastic Leukemia;Cancer Consult;2023-11-18
3. Using Measurable Residual Disease to Optimize Management of AML, ALL, and Chronic Myeloid Leukemia;American Society of Clinical Oncology Educational Book;2023-06
4. SOHO State of the Art Updates and Next Questions: Measurable Residual Disease in Acute Lymphoblastic Leukemia - Optimization and Innovation in 2022 and Beyond;Clinical Lymphoma Myeloma and Leukemia;2022-12
5. Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients;Haematologica;2022-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3